Unitedhealth Group INC Form 4 insider transactions
NYSE
Timothy Noel, Chief Executive Officer of UHC, reports the disposal of common stock in UnitedHealth Group on February 14, 2025.
NYSE
Andrew Witty, CEO of UnitedHealth Group, reports the disposal of common stock to cover tax obligations.
NYSE
Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports a transaction involving common stock on February 14, 2025.
NYSE
Erin McSweeney, EVP & Chief People Officer of UnitedHealth Group, reports the disposal of common stock to cover tax obligations.
NYSE
John F. Rex, President & CFO of UnitedHealth Group, reports exercising stock options and disposing of shares to cover taxes.
NYSE
Director Timothy Flynn of UnitedHealth Group Incorporated (UNH) purchased 1,000 shares of common stock at $511.575 per share on January 17, 2025.
NYSE
Director Charles D. Baker acquired 174 shares of UnitedHealth Group common stock as part of his quarterly compensation.
NYSE
Frederick William McNabb III, a director at UnitedHealth Group, acquired 190 shares of common stock as deferred compensation on January 2, 2025.
NYSE
Director Kristen Gil of UnitedHealth Group reported acquiring 112 deferred stock units and 62 shares of common stock as part of her quarterly compensation.
NYSE
A director at UnitedHealth Group has been granted deferred stock units as part of their regular quarterly compensation.
NYSE
A UnitedHealth Group director, John H. Noseworthy, acquired 186 shares of common stock as part of his quarterly compensation.
NYSE
Timothy Patrick Flynn, a director at UnitedHealth Group, acquired 186 shares of common stock through deferred stock units as part of his quarterly compensation.
NYSE
Director Paul R. Garcia of UnitedHealth Group reported acquiring 174 shares of common stock and deferred stock units as part of regular quarterly compensation.
NYSE
Director Stephen J. Hemsley of UnitedHealth Group reported the acquisition of 283 deferred stock units and indirect ownership of common stock through various accounts.
NYSE
Valerie Montgomery Rice, a director at UnitedHealth Group, acquired 186 shares of common stock as part of her quarterly compensation.
NYSE
Director John H. Noseworthy reports acquiring 24 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.
NYSE
Andrew Witty, CEO of UnitedHealth Group, reports acquisition and disposal of common stock due to dividend equivalents on restricted stock units.
NYSE
Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reports acquisition and disposal of common stock due to dividend equivalents paid on restricted stock units.
NYSE
Heather Cianfrocco, Chief Executive Officer of Optum, reports the acquisition of dividend equivalents on restricted stock units of UnitedHealth Group.
NYSE
Stephen J. Hemsley, a director at UnitedHealth Group, filed a Form 4 disclosing the acquisition of shares through dividend equivalents and a gift of shares.
NYSE
Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports acquisition of common stock through dividend equivalents.
NYSE
John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents related to restricted stock units.
NYSE
Director Charles D. Baker reports acquiring 3 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.
NYSE
Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.
NYSE
Director Timothy Flynn of UnitedHealth Group reported acquiring shares and dividend equivalents, while also transferring shares from a trust.
NYSE
UnitedHealth Group director Valerie Montgomery Rice acquired 24 shares of common stock through dividend equivalents on vested deferred stock units.
NYSE
A UnitedHealth Group director, Michele J. Hooper, acquired 157 shares of common stock through dividend equivalents on vested deferred stock units.
NYSE
Director Kristen Gil of UnitedHealth Group acquired 4 shares of common stock through dividend equivalents, increasing her indirect holdings.
NYSE
Director Paul R. Garcia of UnitedHealth Group reported the acquisition of 6 shares of common stock and adjustments to holdings in various trusts.
NYSE
Frederick William McNabb III, a director at UnitedHealth Group, acquired 30 shares of common stock through dividend equivalents on vested deferred stock units.